Bio-Rad Laboratories | Les Charges D'Exploitation



Operating Expenses Changement Date
Abbott USD 9.06B 298M 2024-12
Agilent USD 1.31B 12M 2025-01
Becton, Dickinson and Co. USD 4.72B 74M 2024-12
Bio Techne USD 249.61M 141K 2024-12
Bio-Rad Laboratories USD 609.1M 23.84M 2024-12
Bruker USD 915.5M 119.2M 2024-12
Charles River Laboratories USD 1.17B 277.88M 2024-12
Danaher USD 5.11B 273M 2024-12
Exact Sciences USD 1.59B 841.72M 2024-12
General Electric USD 8.72B 10.15B 2024-12
Hologic USD 792M 34M 2024-12
Illumina USD 929M 590M 2024-12
IQVIA Holdings USD 3.33B 14M 2024-12
Laboratory Of America USD 3.11B 85M 2024-12
Merck USD 11.33B 1.4B 2024-12
Mettler Toledo International USD 730.58M 884.93M 2024-12
Myriad Genetics USD 249.6M 16.3M 2024-12
Quest Diagnostics USD 2.26B 125M 2024-12
Repligen USD 162.7M 10.11M 2024-09
Revvity USD 610.62M 24.72M 2024-12
Roche Holding CHF 11.43B 1.48B 2024-12
Siemens EUR 16.29B 1.87B 2024-12
Standard Biotools USD 79.54M 2.85M 2024-12
Thermo Fisher Scientific USD 9.38B 619M 2024-12
Tosoh JPY 241.19B 6.47B 2024-12
Waters USD 580.45M 51.28M 2024-12



Bio-Rad Laboratories Les Charges D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2025.